Your browser is no longer supported. Please, upgrade your browser.
ENDP Endo International plc weekly Stock Chart
Endo International plc
Index- P/E- EPS (ttm)-1.59 Insider Own1.00% Shs Outstand246.46M Perf Week15.28%
Market Cap855.22M Forward P/E1.49 EPS next Y2.33 Insider Trans0.00% Shs Float224.85M Perf Month-38.37%
Income-360.60M PEG- EPS next Q0.51 Inst Own92.00% Short Float12.69% Perf Quarter-25.54%
Sales2.91B P/S0.29 EPS this Y62.60% Inst Trans-6.79% Short Ratio3.94 Perf Half Y19.86%
Book/sh-3.82 P/B- EPS next Y0.91% ROA-4.30% Target Price5.89 Perf Year-56.68%
Cash/sh5.90 P/C0.59 EPS next 5Y-11.70% ROE64.70% 52W Range1.97 - 8.55 Perf YTD-26.01%
Dividend- P/FCF25.01 EPS past 5Y-43.10% ROI2.70% 52W High-59.42% Beta1.51
Dividend %- Quick Ratio1.50 Sales past 5Y4.10% Gross Margin46.20% 52W Low76.14% ATR0.60
Employees3172 Current Ratio1.80 Sales Q/Q-2.70% Oper. Margin7.40% RSI (14)41.54 Volatility12.19% 16.49%
OptionableYes Debt/Eq- EPS Q/Q20.60% Profit Margin-14.50% Rel Volume0.47 Prev Close3.77
ShortableYes LT Debt/Eq- EarningsFeb 26 BMO Payout- Avg Volume7.23M Price3.47
Recom3.00 SMA20-11.42% SMA50-33.59% SMA200-18.06% Volume3,407,127 Change-7.96%
Jan-03-20Upgrade Piper Jaffray Neutral → Overweight $5 → $7
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-17-19Downgrade Citigroup Buy → Neutral
Jun-11-19Initiated Barclays Equal Weight
May-13-19Downgrade JP Morgan Neutral → Underweight
Mar-20-19Initiated SunTrust Buy
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
Feb-14-18Initiated B. Riley FBR, Inc. Buy $10
Jan-03-18Reiterated Mizuho Buy $14 → $12
Jan-03-18Initiated Leerink Partners Outperform $12
Dec-12-17Initiated Guggenheim Neutral $8.50
Nov-10-17Reiterated RBC Capital Mkts Sector Perform $9 → $8
Sep-28-17Initiated Goldman Sell $7
Mar-27-20 06:45PM  Covid-19 Could Benefit Generic Drug Companies -7.96%
11:30AM  Why Is Endo (ENDP) Down 33% Since Last Earnings Report? Zacks
Mar-19-20 10:03AM  The Coronavirus Outbreak Has Derailed Settlements in the Opioid Litigation +31.58%
Mar-12-20 12:14AM  Edited Transcript of ENDP earnings conference call or presentation 26-Feb-20 1:00pm GMT Thomson Reuters StreetEvents -9.72%
Mar-06-20 10:06AM  Implied Volatility Surging for Endo International (ENDP) Stock Options Zacks -7.82%
Mar-03-20 09:00AM  These 3 Biotech Stocks Are Outperforming Their Peers Here's Why Investor's Business Daily -5.43%
Mar-02-20 08:26AM  Does Market Volatility Impact Endo International plc's (NASDAQ:ENDP) Share Price? Simply Wall St.
Feb-27-20 03:15PM  Endo's (ENDP) Earnings & Revenues Trump Estimates in Q4 Zacks -11.34%
Feb-26-20 07:35AM  Endo International (ENDP) Q4 Earnings and Revenues Top Estimates Zacks
06:08AM  Drugmaker Endo posts smaller loss on asset impairment charges Reuters
06:00AM  Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results PR Newswire
06:00AM  Endo International plc to Host Earnings Call ACCESSWIRE
Feb-20-20 01:26PM  Endo International chooses a familiar face to be new CEO American City Business Journals
Feb-19-20 04:20PM  Endo Names Blaise Coleman President and Chief Executive Officer PR Newswire +5.21%
04:20PM  Endo Names Blaise Coleman President and Chief Executive Officer CNW Group
04:20PM  Endo Appoints Mark G. Barberio to Board of Directors PR Newswire
04:20PM  Endo Appoints Mark G. Barberio to Board of Directors CNW Group
12:31PM  Earnings Preview: Endo International (ENDP) Q4 Earnings Expected to Decline Zacks
Feb-12-20 10:55AM  Small-Cap Healthcare ETF Outperforming in 2020: 5 Top Stocks Zacks
Jan-27-20 05:20PM  Here's Why You Should Add BioDelivery Stock to Your Portfolio Zacks
04:20PM  Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States CNW Group
Jan-24-20 05:00PM  Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results PR Newswire -10.24%
05:00PM  Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results CNW Group
Jan-20-20 08:17AM  J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge Zacks
Jan-14-20 12:00PM  Endo reaches $8.75M opioid settlement with Oklahoma American City Business Journals +15.40%
Jan-13-20 07:48PM  Oklahoma sues three opioid distributors over man-made crisis MarketWatch
09:11AM  Endo Up on Opioid Abuse Settlement Agreement With Oklahoma Zacks
Jan-10-20 03:09PM  Endo settles opioid suit with Oklahoma AG MarketWatch
11:50AM  Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million PR Newswire
Dec-30-19 09:12AM  Will J&J be Able to Overcome Its Legal Troubles in 2020? Zacks
Dec-20-19 08:40AM  Implied Volatility Surging for Endo (ENDP) Stock Options Zacks
Dec-17-19 05:00PM  Endo to Participate at J.P. Morgan Healthcare Conference PR Newswire
Dec-10-19 08:06AM  Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States CNW Group
Dec-09-19 01:08PM  Did Hedge Funds Drop The Ball On Endo International plc (ENDP) ? Insider Monkey -5.17%
Dec-04-19 11:30AM  Why Is Endo (ENDP) Up 12.3% Since Last Earnings Report? Zacks +10.32%
08:54AM  Options Traders Expect Huge Moves in Endo (ENDP) Stock Zacks
07:59AM  J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders Zacks
Nov-29-19 09:13AM  BioDelivery's Belbuca Sales & Symproic Addition Encouraging Zacks +6.28%
Nov-27-19 07:34AM  Fed Reportedly Opens Criminal Investigation on Opioid Makers Zacks
Nov-26-19 01:21PM  Shares of opioid makers and distributors drop on criminal probe MarketWatch -5.52%
07:08AM  Shares of generic drugmakers rise on hope that legal issues are nearing an end MarketWatch
Nov-25-19 12:49PM  Shares of generic drugmakers jump in morning trading MarketWatch
Nov-22-19 05:00PM  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference CNW Group
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
10:22AM  Company News For Nov 21, 2019 Zacks
Nov-20-19 07:25AM  The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data Benzinga
Nov-19-19 04:54PM  Teva, Bausch Could Be Next to File for Bankruptcy
04:10PM  Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite CNW Group
Nov-18-19 05:07AM  Imagine Owning Endo International (NASDAQ:ENDP) And Trying To Stomach The 94% Share Price Drop Simply Wall St.
Nov-14-19 10:20AM  BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
Nov-08-19 07:52AM  Edited Transcript of ENDP earnings conference call or presentation 5-Nov-19 12:30pm GMT Thomson Reuters StreetEvents
Nov-06-19 02:34PM  Endo CEO to step down when successor is named MarketWatch -5.74%
Nov-05-19 03:56PM  Endo begins search for a new CEO American City Business Journals -8.54%
10:42AM  Endo (ENDP) Q3 Earnings & Revenues Beat Estimates, Down Y/Y Zacks
05:30AM  Endo International Plc to Host Earnings Call ACCESSWIRE
Nov-04-19 06:45PM  Endo International (ENDP) Q3 Earnings and Revenues Top Estimates Zacks
05:14PM  UPDATE 1-Endo quarterly profit beat fueled by sterile injectables Reuters
04:33PM  Endo posts smaller third-quarter loss, CEO to retire Reuters
04:15PM  Endo Reports Third-Quarter 2019 Financial Results PR Newswire
04:15PM  Endo Reports Third-Quarter 2019 Financial Results CNW Group
04:15PM  Endo Implements CEO Succession Plan PR Newswire
04:15PM  Endo Implements CEO Succession Plan CNW Group
Nov-01-19 07:05AM  'The Trend Is Your Friend' +5.01%
Oct-29-19 10:33AM  Earnings Preview: Endo International (ENDP) Q3 Earnings Expected to Decline Zacks
Oct-28-19 12:03PM  Is Endo International plc (ENDP) Going To Burn These Hedge Funds ? Insider Monkey
07:30AM  Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation CNW Group
Oct-25-19 07:30AM  Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA) CNW Group
Oct-24-19 02:48PM  Why Are Endo Shares Trading Lower? Benzinga -8.21%
07:30AM  Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting CNW Group
Oct-23-19 07:30AM  Movapo® (apomorphine hydrochloride) for Patients with Advanced Parkinson's Disease Now Reimbursed in Most Canadian Provinces CNW Group
Oct-22-19 11:29AM  Jim Cramer Gives His Take On AMD, Merck And More Benzinga
Oct-21-19 09:58AM  Major indexes in the green, tech mixed Yahoo Finance Video
08:08AM  UPDATE 9-Drug firms avert landmark opioid trial as talks on $48-bln settlement set to resume Reuters
Oct-18-19 09:11PM  UPDATE 6-Opioid settlement talks fail, landmark trial expected Monday Reuters
07:00AM  Judge's unorthodox approach has huge opioid settlement within reach Reuters
Oct-14-19 07:04PM  Johnson & Johnson's (JNJ) Legal Problems Continue to Worry Investors Zacks -9.31%
Oct-07-19 06:30AM  Nevakar Enters into $17.5 Million Product Financing Agreement with H.I.G. Capital Partners for Continued Development of Injectable Products PR Newswire
Oct-03-19 11:16AM  J&J Settles Ahead of Multi-District Opioid Trial, Stock Up Zacks +12.70%
07:37AM  When Can We Expect A Profit From Endo International plc (NASDAQ:ENDP)? Simply Wall St.
Oct-02-19 05:00PM  Endo to Announce Third-Quarter 2019 Financial Results PR Newswire
12:41PM  The Market Tells Opioid Drugmakers to Settle Up Bloomberg
Oct-01-19 05:02PM  Opioid makers, distributors face shaky future as legal woes mount Yahoo Finance
10:13AM  Opioid Makers Gain on View Theyll Use Purdue Deal as Model Bloomberg
08:46AM  Mallinckrodt Up on Settlement Agreement With Ohio Counties Zacks
Sep-30-19 08:43PM  Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits: WSJ Reuters
08:38PM  UPDATE 1-Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits -WSJ Reuters
05:49PM  Drugmakers look to use Purdue Pharma's bankruptcy to settle opioid suits -WSJ Reuters
11:50AM  Endo dismisses lawsuit against the FDA after two-year battle American City Business Journals
07:30AM  Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy PR Newswire
Sep-27-19 06:38AM  Endo International's Generic Wilson's Disease Drug Gets FDA Approval +10.19%
Sep-24-19 08:48AM  Mallinckrodt's StrataGraft Tissue Phase III Data Positive Zacks
Sep-21-19 04:22AM  Edited Transcript of ENDP earnings conference call or presentation 6-Aug-19 11:30am GMT Thomson Reuters StreetEvents
Sep-16-19 03:14PM  OxyContin maker Purdue Pharma files for bankruptcy Yahoo Finance Video +8.25%
09:33AM  Mallinckrodt and Other Opioid Stocks Are Falling After Purdue Pharma Announced Its Bankruptcy
Sep-11-19 04:06PM  Francis Chou's Chou Europe Fund Semi-Annual 2019 Commentary
12:13PM  Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up Zacks
Sep-10-19 04:21PM  Francis Chou's Chou Associates Fund Semi-Annual 2019 Letter +30.29%
04:56AM  Endo Files BLA for CCH With the FDA for Cellulite Candidate (Revised) Zacks
Sep-09-19 05:28PM  Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties Zacks -11.91%
09:50AM  Endo International Files BLA for Label Expansion of Xiaflex Zacks
Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Its U.S. Branded - Specialty & Established Pharmaceuticals segment provides branded prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain, and orthopedics. This segment offers XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL Nasal Spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN Gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; FORTESTA Gel for men suffering from hypogonadism; EDEX to treat erectile dysfunction; and TESTIM for TRT in conditions associated with a deficiency or absence of endogenous testosterone. The company's U.S. Branded - Sterile Injectables segment offers branded sterile injectable products, such as VASOSTRICT, ADRENALIN, and APLISOL; and generic sterile injectable products. Its U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. It sells its branded pharmaceuticals and generics directly to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. The company was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coleman BlaiseEVP, Chief Financial OfficerFeb 25Option Exercise0.0030,3950148,724Feb 25 04:44 PM
Campanelli PaulPresident, CEOFeb 25Option Exercise0.00208,4300937,847Feb 25 04:42 PM
Coughlin Terrance JEVP, Chief Operating OfficerFeb 25Option Exercise0.0052,1070308,574Feb 25 04:40 PM
Garella RahulEVP, Intl PharmaceuticalsFeb 25Option Exercise0.009,726040,285Feb 25 04:39 PM
Maletta Matthew JosephEVP, Chief Legal OfficerFeb 25Option Exercise0.0029,5270145,085Feb 25 04:37 PM
Barry Patrick AEVP & Chief Commercial OfficerFeb 25Option Exercise0.0013,199064,960Feb 25 04:35 PM
Boyle Jack D.SVP, ControllerFeb 25Option Exercise0.004,009021,517Feb 25 04:34 PM
KIMMEL ROGER HDirectorSep 16Sale4.0930,000122,70080,000Sep 17 05:23 PM
KIMMEL ROGER HDirectorSep 16Sale4.0925,000102,250123,309Sep 17 05:23 PM
KIMMEL ROGER HDirectorJun 17Sale3.9310,00039,300110,000Jun 19 04:01 PM
KIMMEL ROGER HDirectorJun 17Sale3.9324,95198,057148,309Jun 19 04:01 PM